⚖️ Rhode Island Freezes Cannabis Licensure as Courts Settle What Washington Won't

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today's edition is sponsored by The Hustle, and is published by THC Group. Their support keeps these briefings free and focused on what actually matters.

The federal government has left states to sort out a cannabis and hemp policy mess it will not touch. States are improvising. Operators are trying to scale inside the improvisation. The collisions land in front of local judges, state legislators, county supervisors, ballot drafters, and bankruptcy trustees who never signed up to settle federalism one decision at a time. A Rhode Island federal judge just froze an entire license round on a dormant commerce clause claim. Massachusetts is finally rebuilding a commission that spent years proving how badly diffused authority ages. Nebraska is slow-walking its own voters. Cannabist and Silverpeak both landed in court on the same day asking for two different versions of the same answer. When the referees are this improvised, the quality of the regulators, the quality of the courts, and the quality of the journalism covering them all matter more, not less.

🚨 Rhode Island freezes licensure
🏛️ Beacon Hill finally moves
💸 Cannabist and Silverpeak on the same day

Hemp operators are framing state crackdowns as constitutional overreach rather than just bad policy, and the reframing is landing. In Ohio, a judge temporarily blocked portions of SB 56 after finding the law likely disadvantaged federally lawful hemp products in interstate commerce while insulating the state's marijuana market. In Texas, plaintiffs argue state agencies used rulemaking to rewrite hemp policy after the legislature declined to do it themselves. Law360's Sam Reisman published a useful companion survey this week mapping where dormant commerce clause cases actually sit across the federal system, from California to Connecticut, Massachusetts, Michigan, New York, North Carolina, Washington, Rhode Island, and on up through the Fourth and Ninth Circuits. Judges are not reaching the same conclusions, but the volume itself tells the story. This is what happens when the federal government leaves states to sort out a supply chain it will not touch. States improvise, operators push for scale, and the collisions land in front of whichever local judge draws the docket, appointed or elected. Settling federalism one motion at a time is not how any of this was supposed to work. It is where the work is actually getting done. (MJBizDaily; Law360)

A federal judge in Rhode Island ordered state cannabis regulators to halt both social equity and adult-use licensure while a residency-based constitutional challenge from out-of-state entrepreneurs moves through the courts. This is a real escalation from earlier dormant commerce clause rulings that invalidated residency preferences after the fact. A preliminary injunction halting an entire license round is a different kind of leverage, and it lands in a state that has been trying for years to stand up a durable adult-use market inside a small, politically crowded jurisdiction. Rhode Island operators, hemp operators, and the regulators running the program should all assume the ground under state-by-state equity frameworks is going to keep moving. (Law360)

The Massachusetts House voted 155-0 to approve the conference report on H.5350, doubling the personal possession limit from one ounce to two, dissolving the five-member Cannabis Control Commission in favor of a three-member panel, and handing the governor sole appointment authority. The same bill raises the single-entity license cap from three to six, eliminates the vertical integration mandate for medical operators, creates a debt-delinquency list modeled on alcohol enforcement, and stands up an anonymous tip portal for illegal conduct. Worth noting: the bill terminates the existing commissioners' terms the instant Governor Healey signs it, with a thirty-day window for new appointments. Strip away the commission drama and this is one of the most substantive cannabis reform packages Beacon Hill has passed since 2017. The problem is that the circus sideshow the commission became swallowed the attention that should have gone to the operators and the market. Massachusetts businesses deserve a mature regulator capable of evolving alongside them, and the new three-member agency inherits a fresh to-do list on top of a backlog that has not gone away: social consumption rules, a credible testing protocol, the enduring mission of social equity, and a queue of procedural tidying that has been deferred for too long. The governance reset only matters if the people in the new seats treat the actual work as the work. (Marijuana Moment; State House News Service)

🌿 Consumers do not need a peer-reviewed paper to tell them when trust feels thin. A company-backed survey on pesticide anxiety deserves the usual skepticism, but the directional signal is hard to miss. When buyers start associating home grow with safety and transparency, licensed channels have a credibility problem that marketing cannot paper over. (Business Wire; Royal Queen Seeds)

The Boston Globe editorial board is now applauding Beacon Hill's move to shrink the CCC and modernize the state's cannabis framework, casting the reforms as overdue course correction. The policy substance is real. The harder read is about what the Globe has actually been willing to do. It is easier to celebrate reform once the conference report is headed for a 155-0 vote than it was to apply sustained pressure while the commission was melting down in public view. The “paper of record” for my state covered the meltdown as a gossip column rather than as policy. The Globe chased personalities, leaked grievances, and firings, and showed little appetite for the harder reporting on how cannabis policy actually gets made or what the operators and patients on the receiving end of the dysfunction were losing while coverage stayed fixated on the next sideshow. Editorial boards still carry weight around here. They do not get to skip the journalism, arrive for the ribbon-cutting, and claim the mantle of leadership, particularly when the editorial page has started to read less like a paper of record and more like an extension of the same old boys club it should be holding to account. Massachusetts operators deserved a mature regulator. They also deserved a serious paper covering the story. (The Boston Globe)

Fresh reporting puts more scrutiny on the money trail behind Florida's anti-marijuana campaign and raises a harder question than ordinary campaign hardball. According to High Times, $10 million from a Medicaid settlement moved through the Hope Florida Foundation, into two nonprofits, and then into Keep Florida Clean, the committee that opposed Amendment 3. One of those nonprofits reportedly held less than $50,000 in assets before receiving a $5 million grant and transferring most of it within days. The reporting also maps personnel overlap between Florida prohibition groups and the broader SAM orbit, while stopping short of alleging a direct transfer to national affiliates. We tell each other to follow the money, and on a good day that advice works. On a bad day it is a reminder that when politicians and their allies really want to hide money, they are quite good at it. Keep that in mind as SAM rolls out the next wave of prohibitionist campaigns, including the ones already underway in Massachusetts and Arizona. They do not fight fair, and the infrastructure that moved $10 million through a charitable foundation once is the same infrastructure that will move the next round. (High Times)

🥤 Beverage forecasts keep getting bigger because the category still looks like the cleanest bridge to mainstream adoption. Projections from firms that sell reports deserve a discount, but the directional logic holds. Beverage works best when lawmakers treat it like a disciplined, age-gated packaged goods category instead of a proxy war for every intoxicating hemp fight in America. (Future Market Insights via Morningstar)

Two very different distressed stories broke on the same day. The Cannabist Company Holdings, formerly Columbia Care, got a Delaware bankruptcy court to extend provisional stay protection to its U.S. subsidiaries over a U.S. Trustee objection, as the Canadian parent restructures roughly $220 million in funded debt through Canada's CCAA and a parallel Chapter 15 filing in Delaware. A $130 million Virginia sale has closed, with Ohio ($47 million) and Delaware ($16.5 million) pending and MOUs out on six more states. Meanwhile, Silverpeak, the Aspen luxury retailer that Outside magazine once compared to an Apple Store, filed an emergency motion in Colorado state court asking for a receiver after defaulting on a $13 million loan. Silverpeak is represented by Fairfield & Woods, the firm that literally wrote the canonical playbook on receivership as cannabis's state-law workaround for federal bankruptcy access. The company had already quietly tried to sell itself for $16 to $20 million last year, surrendered its cultivation license, and been sued for $20 million on a broken twenty-year lease. Two companies, two different legal vehicles, one shared conclusion. Columbia Care was a rocket ship of the MSO era. Silverpeak was the luxury darling. Most of the early favorites are now in some form of retrenchment, restructuring, or quiet disassembly. The fastest horse out of the gate is rarely the one that wins the Derby, and cannabis has been an expensive reminder of how little that framing has to do with long-term staying power in a capital-starved, federally contradicted industry. Even so, the Delaware ruling shows the wall around plant-touching restructurings is less absolute than it was a week ago, and Silverpeak's state-court play is the quiet default the rest of the industry has been running for years. (MMJDaily)

Vireo Growth closed on the acquisition of The Hawthorne Gardening Company from Scotts Miracle-Gro, taking $35 million in cash, $58 million in working capital, and $20 million in supply inventory over two years, in exchange for 213 million Vireo shares and warrants for another 80 million. Scotts, through its Good Dog Holdings vehicle, now owns roughly 14 percent of Vireo, up to 19 percent with warrants exercised, and Hawthorne's Chris Hagedorn has been nominated to Vireo's board. Read this for what it is. Scotts spent most of the last decade trying to ride the cannabis cultivation wave directly and the last several years trying to figure out how to get off without writing Hawthorne down to zero. Rolling the asset into an MSO in exchange for equity, a board seat, and a multi-year supply arrangement is the kind of exit that lets Scotts keep a foothold in the category without continuing to absorb quarterly pain. For Vireo, already the seventh-largest MSO by revenue, the deal adds roughly $110 million of combined cash and working capital at a moment when most MSOs cannot raise any of that on public markets. The more interesting read is what it says about the ancillary category. If Scotts has concluded the best exit from direct cannabis exposure is to become a large equity holder in an MSO, the picks-and-shovels thesis of the 2018 to 2022 era has now been formally retired by one of its loudest original evangelists. (New Cannabis Ventures; Vireo Growth)

🥤 Vermont's Cleann is leaning hard into a new name for a familiar category. The Wolcott startup just rolled out a hemp-derived "microtail" in partnership with Cold Hollow Cider, one milligram of THC and fifteen of CBD in a twelve-ounce can of freshly-pressed apple cider, distributed statewide through Farrell and already showing up on bar menus as the Micro Mule and the Micro Apple Spritz. Call it microdose mocktails or microtails, the naming fight is the same fight beverage brands have been running for two years: give consumers a word that tells them what this drink is for and what kind of evening it belongs to. Ritual still matters as much as formulation in this category. (The Brattleboro Reformer)

The final lawsuit over Illinois' original dispensary licensing rollout is finally in court. Well-Being Holistic Group argues the state allowed hundreds of ineligible entries into a Chicago lottery that was supposed to advance social equity goals. Illinois counters that the challenged entries would not have changed the plaintiff's outcome, and Judge Patrick Stanton sounded wary of second-guessing agency vetting without stronger proof of a statutory violation. It was not long ago that Governor JB Pritzker was taking national victory laps on the strength of Illinois' equity framework, including at . This suit is a reminder that no program is perfect and the work of building a credible equity framework is enduring rather than finished. A ruling expected in May should say something about how much deference courts will give when the language of fairness and the mechanics of implementation drift apart. (25News Now)

🥚 One ugly local story can wipe out a year's worth of careful category distinctions in the public mind. The Indiana Easter-egg case has nothing to do with disciplined regulated markets, but opponents will not care. Packaging standards, household safeguards, and category separation remain political necessities because bad facts travel faster than good frameworks. (14 News; Dubois County Dash Camz)

San Diego County is moving toward a commercial cannabis framework for unincorporated areas under the banner of the Socially Equitable Cannabis Program, and rural community planning groups are pushing back hard. The approved direction would permit cultivation, retail, distribution, manufacturing, testing, microbusinesses, and potentially lounges and events across dozens of communities that had been closed to new cannabis activity since 2017. Read the opposition testimony and the objections are almost entirely generic cannabis land-use concerns: odor, water use, traffic, noise, public services, and community character. That is what makes the framing worth watching. The equity label is doing political work. It would be uncomfortable for any supervisor to vote against a program marketed as equity repair, but the underlying decision is really about whether to open a commercial cannabis footprint in unincorporated San Diego at all. The equity provisions sit on top of a commercial ordinance that would need to exist either way. Treating the two as one vote conflates the harder land-use question with the easier political one and leaves both the equity goals and the operators worse off when the inevitable backlash arrives. (The Coast News Group)

A release from MMJ International Holdings argues that CMS's new Beneficiary Engagement Incentive creates room for Medicare-connected care organizations to furnish hemp-derived products while cannabinoid drug developers wait through the formal FDA pathway. The source is self-interested, but the underlying read is straightforward. Washington is quietly tolerating a limited pilot that routes full-spectrum hemp-derived CBD to patients through a Medicare-adjacent side door, while the front door for any cannabinoid-based medicine remains exactly where it has always been. If a company wants to market a specific cannabinoid product as a treatment for a specific condition in the broader market, the answer has not changed: FDA approval, randomized controlled trials with placebos, manufacturing controls, and labeling that can survive agency review. That is a high bar, and it is high for good reasons. The side door is narrow, program-specific, and should not be confused for a shortcut to a real therapeutic claim. (ACCESS Newswire)